Find Academic Supervisors

• Tobacco Cessation
• Health Policy
• Health Insurance Benefit Mandates
• +3 more

Dr. Sara McMenamin is an Associate Professor at the Herbert Wertheim School of Public Health & Human Longevity Science at UC San Diego. She serves as the Associate Director of the MPH program and Interim Assistant Dean for Undergraduate Education . Her research focuses on state-level policies addressing tobacco use and preventive services, particularly health insurance coverage for tobacco dependence treatment in California and nationally. She also co-chairs the California Health Benefits Review Program , evaluating proposed health insurance legislation's medical, cost, and public health impacts. Her work spans public health policy analysis , health insurance mandate evaluations, and tobacco control strategies. Key areas include analyzing the effects of tobacco tax increases (e.g., Proposition 56), tracking smoking trends among youth and adults, and investigating the interplay between e-cigarette use and smoking cessation. She has contributed to studies on fertility preservation mandates, telemedicine for substance use disorders, and health equity in insurance access. Recent research highlights include assessing declines in youth smoking despite e-cigarette surges, evaluating tobacco policy coverage changes in California, and projecting future cigarette consumption trends. Her work often bridges policy implementation and population health outcomes, emphasizing evidence-based approaches. Dr. McMenamin collaborates with interdisciplinary teams and state agencies to translate research into actionable policies. Her contributions span over 150 peer-reviewed publications, with frequent media and policy engagement (e.g., cited in 14+ news outlets for key studies).

Lars E. ErikssonView profile

Professor

• Translational Nursing Research
• Biobehavioral Nursing
• Quality of Life
• +9 more

Professor Lars E. Eriksson is a Registered Nurse with a PhD in Nursing and an MSc in Chemistry, currently serving as a part-time Professor in Nursing at the School of Health and Medical Sciences, City St George's, University of London, and as a full Professor in Nursing at Karolinska Institutet, Stockholm, Sweden, where he leads the Lars E. Eriksson Research Group. His academic journey began with a UC in Nursing in 1985, followed by over a decade of clinical work in hematology, immunology, and HIV care in Stockholm, before transitioning into research and academia. His research is centered on biobehavioral and translational nursing, particularly focusing on health and quality of life among individuals with chronic conditions such as HIV, cancer, and long-term infections. Key areas include disease-related stigma, symptom research, patient-reported outcomes, and biomarker development. He is Principal Investigator for a lung cancer biomarker project funded by the Swedish Research Council and the Swedish PI for the H2020 Magnet4Europe project on mental health in healthcare workplaces. His recent publications show a strong trend in using mixed methods to explore end-of-life communication, death literacy, sexual and reproductive health after cancer, and stigma in chronic illness. He frequently employs patient-reported outcomes, online focus groups, and web-based interventions, often in collaboration with international partners. His work bridges clinical practice, nursing science, and public health. Scientific Awards and Memberships: British HIV Association (BHIVA) National HIV Nurses Association (NHIVNA) Swedish Society of Nursing Swedish Society of Medicine Swedish Society of Medical Microbiology Lars Eriksson has advised numerous PhD and Master’s students, primarily on topics related to quality of life, stigma, and chronic illness. He teaches postgraduate modules including MSc Dissertation, Advanced Practice Dissertation, and Sexual and Reproductive Health. He is affiliated with the Centre for Health Services Research and the Centre for Public Health Research at City St George's.

Nancy KassView profile

Professor

• Bioethics
• Research Ethics
• Public Health Ethics
• +12 more

Nancy Kass is a Professor in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, where she also holds the Phoebe R. Berman Professorship in Bioethics and Public Health. She serves as Vice Provost for Graduate and Professional Education at Johns Hopkins University and is the Interim Chair of the Department of Health Policy and Management. Additionally, she is Deputy Director for Public Health at the Johns Hopkins Berman Institute of Bioethics and co-directs the Johns Hopkins Fogarty African Bioethics Training Program. ScD, Johns Hopkins University, 1989 BA, Stanford University Postdoctoral Fellowship, Kennedy Institute of Ethics, Georgetown University Dr. Kass’s research focuses on the ethical dimensions of public health policy and research, with particular expertise in bioethics, research ethics, public health ethics, informed consent, learning health systems, and global health ethics . Her work addresses ethical challenges in HIV/AIDS, obesity prevention, genetics, and international research. She has developed influential frameworks for ethical oversight in public health and clinical research. Her recent publications (2024–2025) reflect a strong focus on modernizing clinical research ethics, including optimizing informed consent, integrating clinical trials with medical practice, and enhancing data infrastructure. These works emphasize ethical governance, patient-centered decision-making, and the alignment of research with real-world healthcare delivery. Her scholarship spans high-impact journals such as JAMA and Implementation Science , demonstrating sustained scholarly leadership. GBFFR Annual Award, Global Forum on Bioethics in Research, 2016 Member, National Academy of Medicine (formerly Institute of Medicine), 2008 Fellow, Hastings Center, 2007 Delta Omega Honorary Society in Public Health, 1996 AMTRA (Advising, Mentoring, and Teaching Award), Johns Hopkins, 1996 Dr. Kass has played a pivotal role in education and mentorship, having directed the PhD program in Bioethics and Health Policy for 15 years. She currently leads the Fogarty-funded African Bioethics Training Program, advancing global bioethics capacity. She has served on numerous national and international advisory bodies, including the National Cancer Institute’s central IRB, the National Academy of Medicine, and the WHO Ethics Review Committee. Her leadership extends to chairing the national Precision Medicine Initiative central IRB. She is actively involved in research projects such as the CDC Informed Consent Project, Bioethics of Quality Improvement, and Demonstrating Respect and Acceptable Consent Strategies in patient-centered outcomes research. These initiatives underscore her commitment to ethical innovation in public health and clinical practice.

Kelsey SwingleView profile

Assistant Professor

• Biomaterials Science
• Immune Engineering
• Reproductive Biology
• +6 more

Kelsey Swingle is an Assistant Professor of Bioengineering at Rice University, where she leads the Swingle Lab at the intersection of biomaterials science, immune engineering, and reproductive biology. Her research focuses on engineering therapeutic and vaccine technologies with translational potential. Ph.D. in Bioengineering from the University of Pennsylvania B.S.E. in Biomedical Engineering from Case Western Reserve University Dr. Swingle’s research explores the design of lipid nanoparticles (LNPs) and nucleic acid therapeutics for women’s health applications, including pre-eclampsia, preterm birth, and gynecologic cancers. Her work integrates bioengineering principles with immune modulation strategies to develop targeted therapies. The trends in her publications highlight advancements in LNP elasticity optimization for placental mRNA delivery, targeted systemic RNA delivery to the brain, and in utero gene editing applications. Her lab prioritizes interdisciplinary approaches to overcome biological barriers in women’s health. 2025 Solomon R. Pollack Award for Excellence in Graduate Bioengineering Research 2024 Muriel Joan Drew Hege Award for Women in Cellular Immunotherapy Research 2024 Penn Engineering Outstanding Teaching Award 2023 Gordon Research Conference Travel Award 2022 Society for Biomaterials STAR Award 2020 NSF Graduate Research Fellowship The Swingle Lab collaborates with the Texas Medical Center to develop precision nanomedicines. Her team employs in vitro, ex vivo, and in vivo models to study biomaterial interactions with female-specific tissues, emphasizing translational research and inclusive scientific communication.

• Community Wellbeing
• Immigrant Health
• Health Inequalities
• +6 more

Joseph Kangmennaang is an Assistant Professor and Queen's National Scholar in Black Health & Social Change at Queen's University. He holds a PhD from the University of Waterloo, an MA from Western University, and a B.A. from the University of Ghana. His research focuses on the interplay between environment and wellbeing, particularly in sub-Saharan Africa and among Black immigrant communities in North America. He employs social theories, participatory methods, and mixed approaches to address health disparities, with a focus on non-communicable diseases, food/water security, and the impact of racism and social change. His courses include HLTH 397 (Globalization and Black Health) and HLTH 495 (Racism and Health). Research areas include immigrant health equity, syndemics, and the role of place in healthcare access. Collaborations with marginalized communities emphasize participatory action and civic engagement. He has published extensively on topics such as climate change impacts on health, HIV/AIDS knowledge among women in Malawi, and the social determinants of wellbeing in Ghana. His work bridges global health challenges with localized solutions, addressing systemic inequities through interdisciplinary partnerships. Notably, he explores how structural factors like migration, remittances, and agroecology affect household welfare and food security in Malawi and Ghana. His recent studies highlight the mental health implications of discrimination among minoritized Canadians during the pandemic and the spatial distribution of diseases like cholera in Tanzania. He advocates for community-driven interventions to promote wellbeing in resource-limited settings.

Kunihiko KanekoView profile

Professor

• Theoretical Biophysics
• Complex Systems
• Chaos
• +6 more

Kunihiko Kaneko is a Professor at the Niels Bohr Institute, University of Copenhagen, with a distinguished career in theoretical biophysics and complex systems. He received his PhD and MSc in Physics from the University of Tokyo, and has held leadership roles at the Universal Biology Institute and Center for Complex Systems Biology. PhD Physics, 1984 - University of Tokyo MSc Physics, 1981 - University of Tokyo His research spans five primary areas: Universal Biology, Evolutionary Constraints, Ecosystem Dynamics, Neural Cognition, and Universal Anthropology. He has published extensively on multi-level consistency principles, dimensional reduction in biological systems, and reciprocity between robustness and plasticity across scales. Recent publications show strong focus on microbial ecosystems (2025), evolutionary game theory (2025), neural modular architectures (2024), and dimensional reduction in cellular systems (2024). His work bridges physics and biology through dynamical systems theory applied to diverse phenomena from protocells to human societies.

Alexandre MarquesView profile

Assistant Professor

• Microbiology
• Immunology
• Parasitology
• +6 more

Dr. Alexandre Marques is an Assistant Professor at the University of Southern Mississippi. His expertise spans Microbiology, Immunology, and Parasitology, with a focus on vaccine development against parasitic infections like Leishmaniasis, Chagas disease, and Malaria. He holds a PhD from the Universidade de São Paulo (2007) and teaches courses such as Gen Microbiology and Microorg Hth Di at the university. His research integrates immunological, clinical, and molecular approaches to understand parasitic disease mechanisms and therapeutic interventions. Notable areas include α-Gal immunization strategies, transcriptomic analysis of breast cancer, and vaccine design against Leishmania. He has also explored applications in aquaculture nutrition and cosmetic safety assessments. Dr. Marques’ work spans interdisciplinary collaborations, including veterinary medicine, nanotechnology-based drug delivery, and antimicrobial stewardship in pediatrics. His contributions to animal models for Chagas disease and canine visceral leishmaniasis highlight translational research impact. Key themes in his publications include immune response modulation, pathogen-host interactions, and biomarker discovery in chronic infections. He has published over 50 articles across microbiology, immunology, and biomedical engineering since 2007.

Jude M. PhillipView profile

Assistant Professor

• Aging
• Mechanobiology
• Cancer Biology
• +5 more

Jude M. Phillip, PhD, is an Assistant Professor in the Departments of Biomedical Engineering and Chemical and Biomolecular Engineering at Johns Hopkins University. His research integrates engineering principles with aging and cancer biology to develop cell-based biomarkers and mechanistic insights into age-related diseases. He leads the Phillip tiME Lab, which focuses on aging dynamics, tumor microenvironment interactions, and translational technologies. Education : PhD, Chemical and Biomolecular Engineering, Johns Hopkins University, 2015 Postdoctoral Research, Melnick/Cerchietti Labs, Weill Cornell Medicine, 2016-2020 B.Eng, Chemical Engineering, City College of New York, 2010 Research Interests : Dr. Phillip’s work spans aging mechanisms, cancer biology, and mechanobiology. Key areas include: Cell-based biomarkers for aging and disease Scale-dependent aging pathways Lymphoma tumor-immune microenvironment (tiME) Single-cell profiling of senescence subtypes ECM mechanoregulation of stem cell fate His lab employs longitudinal cell profiling, data science, and clinical measures to bridge biological aging research with translational medicine. Recent Highlights : 2025: NIH R35 MIRA Award for lymphoma microenvironment research 2024: Johns Hopkins Catalyst Award for aging biomarker studies 2023: AFAR-Glenn Foundation Award for senescence subtype classification Lab & Collaborations : The Phillip Lab collaborates with the Institute for NanoBioTechnology and maintains a living patient-derived tumor biorepository for lymphoma studies. Current projects include ovarian aging organoid models and immune-mechanical interactions in cancer progression.

• Plant Developmental Biology
• Epigenetics
• Plant Genetics
• +5 more

Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement

Michael J. MitchellView profile

Associate Professor

• Biomaterials Science
• Drug Delivery
• Cancer Therapy
• +7 more

Michael J. Mitchell is an Associate Professor in the Department of Bioengineering at the University of Pennsylvania. His research focuses on overcoming biological barriers to drug delivery through biomaterials science, nanotechnology, and cellular engineering. Key areas include mRNA lipid nanoparticle development for cancer therapy, immunotherapy, genome editing, and regenerative medicine. His lab has pioneered placental-targeted drug delivery for in utero treatments and developed scalable microfluidic manufacturing processes for vaccines. Education: PhD in Bioengineering (University of Pennsylvania) Postdoctoral Training in Nanomedicine Research Interests: Dr. Mitchell’s work integrates biomaterials with biological systems to improve drug delivery efficiency. Current projects include: Design of lipid nanoparticles for mRNA and CRISPR delivery Targeted therapies for cancer metastasis and cardiovascular disease Placenta-specific drug delivery systems for maternal-fetal health Bioengineered immune cell therapies using mRNA Recent Achievements: In 2021, his lab published breakthrough work on lipid nanoparticles improving mRNA vaccine stability, featured in Penn Today and MIT Technology Review . Collaborations with CHOP and Penn Medicine have advanced in utero mRNA delivery for congenital diseases. Awards & Grants: Recipient of NIH grants for nanomedicine research and industry partnerships for vaccine development. Active in translational projects with startup companies for clinical nanotechnology applications. Labs & Teams: Lead of the Mitchell Lab at Penn Engineering, which includes over 20 researchers focusing on nanomedicine, biomaterials, and clinical translation.

• Biomedical Imaging
• X-ray Computed Tomography
• Phase-Contrast Imaging
• +6 more

Prof. Julia Herzen holds the Associate Professorship of Physics in Biomedical Imaging at the Department of Physics , TUM School of Natural Sciences , Technical University of Munich . Her research focuses on advancing X-ray imaging techniques using synchrotron radiation and laboratory sources, with applications in medical diagnostics and tissue analysis. Position: Associate Professor Department: Physics School: TUM School of Natural Sciences University: Technical University of Munich Contact: julia.herzen@tum.de Her core research interests include: Quantitative multi-modal X-ray imaging (spectral & phase-contrast) 3D virtual histology of human tissue Breast cancer detection improvement Lung disease imaging (emphysema, pneumonia) X-ray phase-contrast tomography Dark-field imaging material decomposition Recent publications demonstrate expertise in dark-field imaging for lung pathology , phase-contrast CT for organoid visualization , and spectral X-ray applications in multi-material differentiation . Her team explores clinical translation of X-ray techniques for non-invasive diagnostics . She supervises PhD students and teaches Biomedical Engineering courses, including: Quantitative X-Ray Imaging (3 VI) Image Processing in Physics (2 VO) Biostatistics (2 VO) Advanced Lab Courses in X-ray Micro-CT

Aana Marie VigenView profile

Associate Professor

• Healthcare Ethics
• Medical Ethics
• Racial-Ethnic Inequalities in Healthcare
• +12 more

Aana Marie Vigen is an Associate Professor of Christian Social Ethics at Loyola University Chicago, specializing in interdisciplinary approaches to healthcare and medical ethics. Her work bridges sociology, anthropology, ethnography, and theology, with a focus on racial-ethnic and socio-economic disparities in health and healthcare. She actively engages in teaching at both undergraduate and graduate levels and contributes to academic discourse through publications and collaborations. Bachelor of Arts in Spanish, Religion, and Hispanic Studies from St. Olaf College Masters in Theology and Ethics from the Graduate Theological Union and Pacific Lutheran Theological Seminary Doctorate in Social and Theological Ethics from Union Theological Seminary, New York City Dr. Vigen’s research explores the intersection of human and ecological health, particularly in the context of climate change, as well as feminist ethics, white anti-racism, and theological anthropology. Her recent publications address prenatal genetic testing, reproductive justice, and the role of Christian ethics in confronting systemic health inequities. She employs ethnographic methods to engage with marginalized voices and contemporary bioethical challenges. Dr. Vigen co-edited Ethnography as Christian Theology and Ethics (2011) and contributed to interdisciplinary anthologies on bioethics, gender, and religious authority. Her work emphasizes the integration of theological reflection with empirical research to address issues like racial disparities in healthcare and ethical implications of genetic counseling. She is a member of the Society of Christian Ethics (SCE) and the American Academy of Religion (AAR) and served on the national ELCA Genetics Taskforce from 2008–2011.

• Pharmaceutical Care
• Interdisciplinary Collaboration
• Patient-Centered Care
• +5 more

Veerle Foulon serves as full professor and dean of the Faculty of Pharmaceutical Sciences at KU Leuven, Belgium. She leads the Unit Clinical Pharmacology and Pharmacotherapy within the Department of Pharmaceutical and Pharmacological Sciences. Her institutional leadership roles include membership in the University Council, Academic Council, and Special Academic Council as dean, alongside positions in the Board for Alumni Relations and Biomedical Sciences Group Management. Leuven Centre for Health Humanities Leuven Interdisciplinary Centre for Meaning and Lived Religion LC&Y - KU Leuven Institute for Child and Youth LIVO – KU Leuven Institute for Educational Research LKI - KU Leuven Cancer Institute Her research centers on pharmaceutical care, interdisciplinary collaboration, patient-centered care, and rational pharmacotherapy. Key focus areas include medication safety during pregnancy through the BELpREG registry, antimicrobial stewardship in Ethiopian healthcare settings, and person-centered medication optimization for elderly patients in nursing homes. She emphasizes real-world data collection and interdisciplinary approaches to address critical gaps in medication safety for vulnerable populations. Analysis of her recent publications reveals dominant themes in pregnancy medication safety (particularly via the BELpREG cohort), nursing home medication pathways, and antimicrobial resistance interventions. Her work consistently involves large-scale international collaborations across Europe and Ethiopia, addressing systemic challenges in pharmaceutical care through mixed-methods designs and registry-based studies. As principal investigator on major funded projects extending to 2028—including antimicrobial resistance initiatives in Ethiopia and pregnancy medication safety studies—she directs substantial research grants. Her leadership in interdisciplinary consortia drives innovation in medication optimization, though specific doctoral advisees are not documented in the provided materials. Current projects demonstrate strong translational focus with direct clinical implementation pathways. Embedded within multiple Leuven research institutes, she fosters cross-disciplinary collaborations through the BELpREG consortium and antimicrobial stewardship networks. Her work actively involves partnerships with Ethiopian tertiary hospitals, European pregnancy registries, and Belgian nursing home networks to develop and implement evidence-based pharmaceutical care models.

Celia ByrneView profile

Associate Professor

• Public Health
• Preventive Medicine
• Epidemiology
• +3 more

Celia Byrne is an Associate Professor in the Department of Preventive Medicine and Biostatistics at the Uniformed Services University of the Health Sciences (USUHS). She holds a dual appointment in the Department of Epidemiology and Biostatistics. Her academic background includes a Bachelor's in Biology from Earlham College and a PhD/Master's in Epidemiology from UCLA. Her research focuses on environmental exposures, breast cancer epidemiology, and public health disparities. Key projects include investigating polycyclic aromatic hydrocarbons (PAHs) and breast cancer risk, environmental metal impacts on breast density, and the effects of SARS-CoV-2 on long-term health outcomes in military populations. She has led federally funded studies, such as the US Army-funded PAHs and Breast Cancer Risk project and a National Institute of Environmental Health Sciences study on metal/metalloid exposures. Byrne’s work bridges epidemiology and biostatistics, emphasizing methodological rigor in analyzing population-level health data. Her recent studies address post-COVID-19 sequelae, vaccination impacts, and racial disparities in endocrine-disrupting chemical exposure. Collaborations include multidisciplinary teams across military and civilian institutions. Her publications span environmental health, infectious disease epidemiology, and breast cancer research. Notable contributions include analyses of long-COVID symptoms, hybrid immunity mechanisms, and the role of acculturation in breast density among immigrant populations.

Søren Lundbye-ChristensenView profile

Associate Professor

• Biostatistics
• Medical Statistics
• Cardiovascular Research
• +7 more

Søren Lundbye-Christensen is an Associate Professor and Biostatistician affiliated with the Clinical Institute at the Faculty of Health Sciences, Aalborg University, and Aalborg University Hospital in Denmark. He specializes in biostatistical support for medical research, with a strong emphasis on cardiovascular and epidemiological studies. His research interests include biostatistics, survival analysis, cohort studies, clinical epidemiology, and statistical modeling in public health. He has contributed to a wide array of healthcare research, particularly in cardiovascular diseases, cancer, maternal health, and infectious diseases. His methodological expertise spans time-to-event analysis, registry-based research, and interval-censored data modeling. The recent publications highlight a strong trend in applying advanced statistical methods to large-scale clinical and population-based datasets. His work often involves collaboration with medical researchers to derive prognostic models, validate clinical databases, and assess public health outcomes. Key themes include cardiovascular risk, fertility, cancer biomarkers, and implementation of medical training programs. Scientific Contributions and Recognition: Published over 320 research articles and datasets. Active contributor to methodological advancements in biostatistics. Regular peer reviewer, including for journals like the R Journal. Public engagement through media appearances on statistics and health. Academic Advising and Grants: Søren has supervised 31 student theses, formally serving as PhD supervisor for 14 theses and as a biostatistical advisor for 19 others, primarily in mathematics and statistics. He has participated in numerous research projects funded through institutional and national grants, including studies on seasonal disease trends, postoperative complications, and metabolic disease prediction. His work often involves interdisciplinary collaboration across medicine, public health, and data science. Labs and Research Teams: He is embedded in collaborative research networks at Aalborg University Hospital and Aalborg University, contributing statistical expertise to clinical research groups. He is involved in projects utilizing Danish national health registries and has contributed to the development and validation of clinical databases. His work supports both hypothesis-driven medical research and methodological innovation in biostatistics.